Rheumatoid Arthritis Clinical Aspects: Diagnostic and Remission Criteria

Session Type: ACR Abstract Submissions
Tuesday, November 8, 2011: 2:30 PM-4:00 PM
W196b (McCormick Place West)
Moderators: Deborah P.M. Symmons, FRCP, MD, The University of Manchester and Joseph A. Markenson, MD, Hosp for Special Surgery
2:30 PM
Patients with a Severe Clinical Disease Course Can Be Identified Using Cluster Analysis – Results From a Canadian National Early Arthritis Cohort
Ye Sun, Mount Sinai Hospital, Toronto, ON, Cindy Lim, Mount Sinai Hospital, Toronto, Gilles Boire, CHUS - Sherbrooke University, Sherbrooke, QC, Boulos Haraoui, Institut de Rhumatologie, Montreal, QC, Carol A. Hitchon, University of Manitoba, Winnipeg, MB, Edward C. Keystone, Rebecca MacDonald Centre for Arthritis and Autoimmune Disease, Mount Sinai Hospital, Toronto, ON, Janet E. Pope, St. Joseph's Health Care, University of Western Ontario, London, ON, J. Carter Thorne, Southlake Regional Health Centre, Newmarket, Newmarket, ON, Diane S. Ferland, LaSalle, QC, Vivian P. Bykerk, Brigham & Women's Hospital, Boston, MA and CATCH Investigators, Canada
2:45 PM
Defining Erosive DISEASE Typical of RA In the LIGHT of the 2010 ACR/EULAR Criteria for Rheumatoid Arthritis –PHASE 1.
R. Knevel1, Désirée van der Heijde1, Tom W.J. Huizinga1, Cédric Lukas2, Bernard G. Combe2 and Annette H.M. van der Helm-van Mil1, 1Leiden University Medical Center, Leiden, Netherlands, 2Hopital Lapeyronie, Montpellier, France
3:00 PM
The New ACR/EULAR Definition of Remission in Rheumatoid Arthritis: A Comment on the Patient Global Assessment Criterion
Marloes Vermeer1, Ina H. Kuper1, Arie E. van der Bijl2, Hetty Baan3, Marcel D. Posthumus4, Herman L.M. Brus5, Piet L.C.M. van Riel6 and Mart A.F.J. van de Laar1, 1University of Twente & Medisch Spectrum Twente, Enschede, Netherlands, 2Isala Klinieken, Zwolle, Netherlands, 3Ziekenhuisgroep Twente, Almelo, Netherlands, 4University Medical Center Groningen, Groningen, Netherlands, 5TweeSteden Ziekenhuis, Tilburg, Netherlands, 6Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
3:15 PM
Performance of the New ACR/EULAR Remission Criteria Compared to DAS28 Remission in Unselected Real-Life Patients with Rheumatoid Arthritis
Dörte Huscher1, Katja Thiele2, Sascha Bischoff2, Marina Backhaus3, Martin Aringer4, Ina Kötter5 and Angela Zink1, 1German Rheumatism Research Centre and Charité University Medicine, Berlin, Germany, 2German Rheumatism Research Centre, Berlin, Germany, 3Charité University Medicine, Berlin, Germany, 4Uniklinikum TU Dresden, Dresden, Germany, 5Department of Internal Medicine II, Rheumatology Division, Tübingen, Germany
3:30 PM
RAPID3 Remission Vs New ACR Rheumatoid Arthritis Remission Criteria: RAPID3 Has Similar Utility and May Be Used in Everyday Clinical Care
Yusuf Yazici, Division of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, NY, Maria T. Filopoulos, NYU Hospital for Joint Diseases, New York, NY and Christopher J. Swearingen, University of Arkansas for Medical Sciences, Little Rock, AR
3:45 PM
Title: American College of Rheumatology/European League Aganist Rheumatism Remission Criteria Achievement in Rheumatoid Arthritis: Data From 32 Countries
Nasim A. Khan, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR, Tuulikki Sokka, Jyvaskyla Central Hosp, Jyväskylä, Finland and QUEST-RA, Jyväskylä
See more of: ACR Abstract Submissions

To see other sessions for this day, use the date buttons to the left.